The findings revealed that, compared to optimized medical therapy, bioresorbable scaffold treatment resulted in a greater minimal lumen area without increasing the rate of target lesion failure and showed a trend toward reducing the risk of MACE associated with the target lesion.
← all excerpts
Rationale and Design of the PASSIVATE-CAP Trial: The Preventive Intervention Value of Drug-Coated Balloons in Vulnerable Coronary Atherosclerotic Plaques.
1
—
—